Novo nordisk
Pharma
Data as of 4 Oct 2026
Markdown version
Markdown version
Novo nordisk was mentioned 46 times in 23 outlets across 9 countries over the last 12 months. 26% of that coverage was positive and 11% negative. 85% was editorial rather than PR or paid placement.
MENTIONS · 12M
46
48 all-time
OUTLETS · 12M
23
in 9 countries
AVG SENTIMENT
+0.124
EDITORIAL
85%
7 PR · 39 editorial
Recent coverage
Eli Lilly’s diabetes drug Mounjaro approved to reduce cardiovascular risks - Business Today
businesstoday.in · IN · 1 Sep 2026 · neutral
Novo Nordisk stock consolidates as Wegovy tablet launch and buybacks reshape the obesity story - ad-hoc-news.de
ad-hoc-news.de · DE · 31 Aug 2026 · neutral
Novo Nordisk's Chinese Filing and a 30 Million-Share Buyback: A Stock Caught Between Two Narratives - ad-hoc-news.de
ad-hoc-news.de · DE · 31 Aug 2026 · neutral
Novo Nordisk (NYSE: NVO) details progress on DKK 15B buyback - Stock Titan
stocktitan.net · INT · 31 Aug 2026 · neutral
Novo Nordisk A/S - share repurchase programme - Yahoo! Finance Canada
ca.finance.yahoo.com · CA · 31 Aug 2026 · neutral
Novo Nordisk expects up to DKK15B in buybacks; DKK8.71B repurchased - Stock Titan
stocktitan.net · INT · 31 Aug 2026 · positive
Eli Lilly’s Mounjaro and Novo Nordisk’s Wegovy expand rivalry into cardiovascular drugs - DongA Science
dongascience.com · INT · 31 Aug 2026 · positive
Weekly Recap: 77% 2025 sales patent risk and GLP-1 employer coverage drop - TradingView
tradingview.com · INT · 31 Aug 2026 · neutral
Coverage over time · mentions per month
Mentions per month as a table
| Month | Mentions |
|---|---|
| 2025-11 | 0 |
| 2025-12 | 0 |
| 2026-01 | 1 |
| 2026-02 | 1 |
| 2026-03 | 0 |
| 2026-04 | 0 |
| 2026-05 | 0 |
| 2026-06 | 17 |
| 2026-07 | 0 |
| 2026-08 | 26 |
| 2026-09 | 1 |
| 2026-10 | 0 |
Share of voice among Pharma peers · 12m
| Brand | Mentions | Share |
|---|---|---|
| Eli lilly | 130 | 23% |
| Astrazeneca | 78 | 14% |
| Pfizer | 64 | 11% |
| Johnson & johnson | 59 | 10% |
| Novo nordisk | 46 | 8% |
| Merck | 44 | 8% |
| Sandoz | 41 | 7% |
| Moderna | 38 | 7% |
| Bayer | 36 | 6% |
| Roche | 36 | 6% |
Track Novo nordisk against its rivals
Daily mentions, sentiment, share of voice and alerts — only what is actually about the brand.
Start trackingIs this your brand?
Claim the page to correct aliases, website or sector, and see the full picture.
Claim this page